Gaza: New Displacement Orders Force Thousands To Flee As Famine Looms
15 May 2025
In addition to ongoing bombardment, Israel issued another three displacement orders over the past two days, covering seven per cent of the total area of the territory.
Overall, some 71 per cent of the Gaza Strip is under displacement orders or in Israeli-militarized zones, where the Israeli authorities require humanitarian teams to coordinate their movements.
' These displacement orders come as populations across Gaza are at risk of famine and one in every five people faces starvation,' the agency said.
Thousands uprooted
Evacuation orders announced on Thursday have impacted thousands of residents in 10 neighbourhoods in Deir Al-Balah and Khan Younis, OCHA reported.
Initial assessment indicates that the affected area includes eight wells, five reservoirs, seven humanitarian warehouses, three health clinics and other critical facilities.
Furthermore, displacement orders issued on Wednesday for six neighbourhoods in North Gaza governorate overlap with parts of zones covered under orders issued the previous day.
'According to preliminary estimates, the newly impacted area is home to approximately 100,000 people,' OCHA said.
Some 30 sites for internally displaced people, six temporary learning spaces serving approximately 700 students, and several water and sanitation facilities have been affected.
Fleeing families return
Humanitarian partners report that several hundred families fled parts of the designated areas on Wednesday, however dozens have since returned due to lack of space and shelter.
Another displacement order was also issued that same day for parts of the Rimal area of Gaza City.
OCHA further reported that on Wednesday Israeli forces hit another school-turned-shelter run by the UN agency that assists Palestine refugees, UNRWA, in the Nuseirat area of Deir Al-Balah on Wednesday. No injuries were reported.
Humanitarians committed to deliver
Meanwhile, the UN and partners on the ground are committed to stay and deliver in the Gaza Strip despite the mounting challenges.
On Wednesday, the World Health Organization (WHO) evacuated 284 patients and their companions from the European Gaza Hospital in Khan Younis to Europe and the United Arab Emirates. Israeli forces hit the hospital premises twice one day prior to the scheduled evacuation.
European Gaza Hospital is no longer functional following the attack, WHO Director-General Tedros Adhanom Ghebreyesus said in a tweet on Thursday.
'The hospital's closure has cut off vital services including neurosurgery, cardiac care, and cancer treatment—all unavailable elsewhere in Gaza,' he said.
He added that another strike near the Indonesian Hospital 'spread fear, disrupted access, and raised the risk of closure.'
Tedros underlined that 'hospitals must be protected', saying 'they must never be militarized or targeted.'
Time is of the essence
More than two months have passed since Israel implemented a full blanket ban on the entry of cargo into the Gaza Strip, including aid and other life-saving supplies, which continues to drive hunger and deprivation.
UN teams report that the number of hot meals provided by community kitchens has fallen from one million to just 249,000 a day.
OCHA Spokesperson Olga Cherevko told UN News that the situation will continue to worsen as supplies run down, forcing more kitchens to close.
' People are terrified and are telling me every day that they don't know how they will survive,' she said.
'I have passed several kitchens in the past few days where crowds of people were standing with empty pots and despair in their faces, and these people were being told to go home because all the food had run out for that day.'
The UN and partners have 9,000 truckloads of vital supplies ready to move into Gaza, including food assistance to feed millions for months. Thousands more trucks full of aid are on standby.
OCHA reiterated that as long as the full blockade is not immediately lifted, the already limited assistance available will shrink even further, warning ' time is of essence to prevent further death.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
2 hours ago
- RNZ News
Polio vaccines set to arrive in PNG next week, says health minister
Then-WHO regional director for the Pacific, Dr Shin Young-soo provides oral polio vaccine in Lae in Morobe in 2018. Photo: supplied Papua New Guinea's health minister, Elias Kapavore, says polio vaccines are set to arrive in the country next week. The World Health Organisation declared an outbreak of the disease in PNG last month. The Post Courier reported that as of 6 June, 48 cases of acute flaccid paralysis - a condition characterized by rapid onset of muscle weakness or paralysis, but not a disease in itself - had been reported across 11 provinces. Of these, 20 tested negatives for poliovirus, and 28 remain under investigation. Kapavore said the primary objective is to protect children from paralysis and prevent further virus transmission. Kapavore said vaccines are scheduled to arrive between 16 and 20 June. The estimated cost for two rounds of the vaccination campaign is 88 million kina (US$21.4m). So far, 74 million kina has been secured through the PNG and Australian governments and from the Global Polio Eradication Initiative, as well as technical and logistical support from WHO and UNICEF, including the full cost of the nOPV2 vaccine supply. During the recent World Health Assembly in Geneva, Kapavore presented PNG's national statement, reaffirming its commitment to the Global Polio Eradication Initiative and advocating for cross-border coordination, especially with Indonesia. "The genetic link to the Indonesian strain [of polio] highlights the urgency of strengthening biosecurity capacity at the Papua New Guinea-Indonesia border," he said. "We must scale up surveillance and immunisation at these points of entry through coordinated efforts by the Departments of Health, Agriculture, Defence, Immigrations and Border Security, to prevent future cross-border transmission of polio and other infectious diseases." He called upon every MP to actively support vaccination and awareness efforts in their constituencies. Meanwhile, the World Health Organisation has raised concern about comebacks of vaccine-preventable disease in east Asia and the Pacific. In the first months of 2025, countries like Cambodia, Mongolia, the Philippines and Vietnam have reported a sharp rise in measles cases compared with the same period last year. UNICEF regional director for East Asia and the Pacific, June Kunugi, said measles and polio are highly infectious. "And children are paying the price for gaps in coverage, delayed care, and misinformation. No child should suffer or die from a disease we know how to prevent."
RNZ News
17 hours ago
- RNZ News
US-backed Gaza group suspends aid for a day over threats, Hamas vows to protect UN aid
By Maayan Lubell, Jaidaa Taha and Nidal al-Mughrabi , Reuters A boy carries a box of relief supplies from the Gaza Humanitarian Foundation (GHF), on 29 May 2025. Photo: Eyad Baba / AFP A controversial humanitarian organisation backed by the US and Israel did not distribute any food aid on Saturday (local time), accusing Hamas of making threats that "made it impossible" to operate in the enclave, which the Palestinian militants denied. The Gaza Humanitarian Foundation (GHF), which uses private US security and logistics firms to operate, said it was adapting operations to overcome the unspecified threats. It later said in a Facebook post that two sites would reopen on Sunday. A Hamas official told Reuters he had no knowledge of such "alleged threats." The Hamas-run Gaza government media office said later on Saturday that the GHF operation has "utterly failed on all levels" and that Hamas was ready to help secure aid deliveries by a separate long-running UN-led humanitarian operation. Hamas also called on all Palestinians to protect humanitarian convoys. Israel and the US have accused Hamas of stealing aid from the UN-led operations, which the militants deny. A Hamas source said the group's armed wing would deploy some snipers from Sunday near routes used by the UN-led aid operation to prevent armed gangs from looting food shipments. The UN did not immediately respond to a request for comment. Israel allowed limited UN-led operations to resume on 19 May after an 11-week blockade in the enclave of 2.3 million people, where experts have warned a famine looms. A Palestinian youth who was injured by Israeli fire near a US-backed aid center in the Rafah area, receives treatment at the Nasser hospital in the southern Gaza Strip on 3 June 2025. Photo: AFP The UN has described the aid allowed into Gaza as " drop in the ocean ." Israel and the US are urging the UN to work through the GHF, but the UN has refused, questioning its neutrality and accusing the distribution model of militarising aid and forcing displacement. The GHF began operations in Gaza on 26 May and said on Friday so far it has distributed nearly 9 million meals. While the GHF has said there have been no incidents at its so-called secure distribution sites, Palestinians seeking aid have described disorder and access routes to the sites have been beset by chaos and deadly violence. Dozens of Palestinians were killed near GHF sites between Sunday and Tuesday, Gaza health authorities said. Israel has said it is investigating the Monday and Tuesday incidents but said it was not to blame for Sunday's violence. Palestinian children wait with others for food at a distribution point in Gaza City. Photo: AFP / Majdi Fathi The GHF did not give out aid on Wednesday as it pressed Israel to boost civilian safety beyond its sites, and then on Friday it paused some aid distribution "due to excessive crowding." The Israeli military said on Saturday that 350 trucks of humanitarian aid belonging to the UN and other international relief groups were transferred this week via the Kerem Shalom crossing into Gaza. Israel makes the UN offload aid on the Palestinian side of the crossing, where it then has to be picked by the UN and aid groups in Gaza. The UN has accused Israel of regularly denying access requests and complained that its aid convoys have been looted by unidentified armed men and hungry civilians. Israel has in recent weeks expanded its offensive across the Gaza Strip as US, Qatari and Egyptian-led efforts to secure another ceasefire have faltered. Medics in Gaza said 55 people were killed in Israeli strikes across the enclave on Saturday. Israeli military vehicles deploy at Israel's southern border with the Gaza Strip. Photo: AFP/JACK GUEZ The Palestinian Health Ministry said on Saturday that Gaza's hospitals only had fuel for three more days and that Israel was denying access for international relief agencies to areas where fuel storages designated for hospitals are located. There was no immediate response from the Israeli military or COGAT, the Israeli defence agency that coordinates humanitarian matters with the Palestinians. Meanwhile, the Israeli military said it had uncovered "an underground tunnel route, including a command and control centre from which senior Hamas commanders" operated beneath the European Hospital compound in southern Gaza. The war erupted after Hamas-led militants took 251 hostages and killed 1,200 people, most of them civilians, in the 7 October 2023 attack, Israel's single deadliest day. Israel's military campaign has since killed more than 54,000 Palestinians, most of them civilians, according to health authorities in Gaza, and flattened much of the coastal enclave. Israeli Defence Minister Israel Katz said on Saturday the Israeli military had retrieved the body of a Thai agricultural worker held in Gaza since the October 2023 attack. Nattapong Pinta's body was held by the Mujahedeen Brigades militant group, and recovered from Rafah in southern Gaza, Katz said. - Reuters
Scoop
a day ago
- Scoop
Despite Being Preventable And Curable Cervical Cancer Remains 4th Biggest Cancer In Women
Prophylactic vaccination against human papilloma virus (HPV) – which is one of the most common sexually transmitted infections and which causes cervical cancer – and screening, and treatment of pre-cancer lesions are very cost-effective strategies … Cervical cancer (cancer of the cervix) is preventable and curable, only if it is detected early and managed effectively. Yet it is the 4th most common cancer among women worldwide, with the disease occurring in 660,000 women and claiming the lives of 350,000 women in 2022 worldwide, as per the World Health Organization (WHO). China, India, and Indonesia had the highest number of cervical cancer cases in 2022. Moreover 42% of cervical cancer cases and 39% of deaths associated with it worldwide, took place in China and India- 23% cases and 16% deaths in China, and 19% cases and 23% deaths in India. India reported over 123,000 new cases of cervical cancer and around 77,000 deaths – highest number of deaths worldwide in 2022. Cervical cancer disproportionately affects younger women, and as a result, 20% of children who lose their mother to cancer do so due to cervical cancer, says WHO. As cervical cancer is the only cancer that can be eliminated, the WHO Director General had called upon the governments in 2018 to eliminate it. All governments globally committed to do so by 2030 (by endorsing the global strategy to eliminate cervical cancer by 2030 at the World Health Assembly 2020). But despite some progress, the world is way off the mark from the elimination goal in 2025. Where cervical cancer burden is greatest, access to lifesaving services is most broken Cervical cancer reflects the global inequities between the Global North and the Global South: The highest rates of cervical cancer incidence and mortality are in low- and middle-income countries. In fact, 94% of the cervical cancer deaths in 2022 took place in these countries where access to health services is appalling. This reflects major health inequities which are driven by lack of access to vaccination, cervical cancer screening and treatment services. Prophylactic vaccination against human papilloma virus (HPV) – which is one of the most common sexually transmitted infections and which causes cervical cancer – and screening, and treatment of pre-cancer lesions are very cost-effective strategies to prevent cervical cancer. WHO's call to deliver on #HealthForAll dates to the 1970s, but even now gaping health inequities and injustices plague the health systems – especially in the Global South. Vaccines against HPV have existed since almost 20 years now. No surprise for guessing that both Cervarix (made by Glaxo) and Gardasil (made by Merck) were made in the rich nations – and their rollout in the Global South has been far from ideal. In 2022, India-based Serum Institute in collaboration with the Department of Biotechnology of the government of India developed India's first indigenously produced HPV vaccine called Cervavac. So, now there is a vaccine developed in the Global South too. But its rollout is far from ideal as of now. It is still not a part of India's public health programme, for instance. Same inequities block access to HPV screening in the Global South 'Almost all cervical cancers (~95%) are caused by persistent HPV infection. Women living with HIV are 6 times more likely to develop cervical cancer compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV,' said Dr Kuldeep Singh Sachdeva, former head of Indian government's national TB and HIV programmes. Dr Sachdeva was speaking at the National Dialogue and stakeholder meet organised by National Coalition of People living with HIV in India (NCPI Plus) bringing together over 100 community leaders from almost all states of India. Dr Sachdeva currently leads Molbio Diagnostics as President and Chief Medical Officer. He was speaking ahead of 10th Asia-Pacific AIDS & Co-Infections Conference (APACC 2025), Japan; 2nd Asia Pacific Conference on Point of Care Diagnostics for Infectious Diseases (POC 2025), Thailand; and 13th International AIDS Society Conference on HIV Science (IAS 2025), Rwanda. Cervical cancer screening efforts in most settings of the Global South have long been hampered by reliance on outdated methods like pap smears and visual inspection with acetic acid (VIA) test, both of which suffer from poor sensitivity, high subjectivity, and dependence on specialised infrastructure. Advanced molecular HPV tests developed by the Global North, while highly accurate than pap smear and VIA, remain inaccessible for most women living in peripheral, rural, and resource-limited settings, especially of the Global South. India's first point-of-care HPV test that can be deployed at point-of-need in the Global South In April 2025, India's first ever indigenously developed RT-PCR molecular test for HPV on Truenat (called HPV-HR Plus) got an independent multi-centric validation done by Government of India's Department of Biotechnology, Biotechnology Industry Research Assistance Council (BIRAC) and Grand Challenges India. Truenat HPV-HR Plus test is made by Molbio Diagnostics in India. This independent validation of Truenat HPV-HR Plus was conducted under the study 'Validating Indigenous Human Papilloma Virus (HPV) Tests for Cervical Cancer Screening in India.' The study involved leading Indian government's research institutes, including All India Institute of Medical Sciences (AIIMS) Delhi, ICMR National Institute for Cancer Prevention and Research (NICPR) Noida, and ICMR National Institute for Research in Reproductive and Child Health (NIRRCH) Mumbai, in collaboration with WHO's International Agency for Research on Cancer (IARC). There are over 200 genotypes of HPV but those that put the infected person at risk of developing cervical cancer are few. Truenat HPV-HR Plus molecular test enables detection for 8 HPV high-risk genotypes – which account for over 96% cervical cancer cases worldwide. These HPV high-risk genotypes include 16, 18, 31, 33, 35, 45, 52 and 58. Out of these, 16 and 18 high-risk genotypes dominate globally as 77% of invasive cervical cancer cases are associated with them. These high-risk genotypes can also cause cancer of the anus, penis, vagina, vulva, and oropharynx (throat). Raising cervical cancer awareness and health literacy among people with HIV As women living with HIV are 6 times more at risk of cervical cancer, communities and networks of people with HIV must come forward to find ways to integrate cervical cancer screening as well as for other cancers (such as breast cancer) programmatically and in people-centred manner, said Daxa Patel, co-founder of National Coalition of People living with HIV in India (NCPI Plus) and its former President. Agrees Pooja Mishra, Secretary of NCPI Plus that it is unacceptable when cervical cancer, which is preventable and curable – and the only cancer which can be eliminated – still kills 350,000 women worldwide. We also need to raise awareness, health and treatment literacy among the young people, said Mishra. That is why NCPI Plus took leadership in organising a national dialogue and stakeholder consultation on preventing cancers among people with HIV, especially women. Truenat HPV-HR Plus test is critical for closing the screening gap, particularly for asymptomatic women and women who are at higher risk for persistent HPV infection. By shifting HPV screening closer to the most-at-risk people and communities, this test ensures early detection, better triaging, and timely treatment – especially in historically underserved populations. Over 10,000 Truenat RT-PCR molecular test machines are already deployed globally in over 85 countries (mostly for TB), and mostly in the Global South nations in remote settings. Truenat is a battery operated (with solar power charging), laboratory independent, de-centralised and point-of-care test that provides highly accurate diagnosis for over 30 diseases (including TB, HPV, HCV, HBV, STIs, COVID-19, etc) within an hour – thus enabling same day test and treat, counselling and follow-up. Superiority of Truenat HPV-HR Plus test Older Pap smear test detects precancerous or cancerous cervical cancer cells whereas Truenat HPV-HR Plus test detects the presence of high-risk HPV DNA (8 genotypes). Pap smear is a cytological screening test and depends on the observing medical expert's skill and slide quality, whereas Truenat is a PCR-based nuclear acid amplification test with very high sensitivity and specificity. False negative reports are higher and false positive reports are also moderate when pap smear is used whereas both are low with Truenat HPV-HR Plus. The most recent validation of Truenat HPV-HR Plus showed 100% specificity and 100% sensitivity. Truenat HPV-HR is designed to work with cervical swab samples collected by a clinician (self-collection of samples is still under evaluation), and it gives highly accurate results in just 60 minutes. Whereas, a pap smear results may take 3-7 days as these are laboratory dependent. Easy to use and with high stability at room temperature, Truenat HPV-HR Plus requires minimal biosafety and is optimised for use at both the laboratory and near-patient settings. This test overcomes shortcomings of current diagnostic methods, including variable sensitivity and specificity, high costs, complex workflows, and dependence on advanced equipment, said Dr Sachdeva. Highlighting the importance of developing health technologies in the Global South, Rajesh S Gokhale, Secretary, Department of Biotechnology, Ministry of Science and Technology, Government of India said, 'Truenat HPV-HR Plus represents the kind of diagnostic innovation we need – dependable, scientifically rigorous, locally developed, and built to serve our public health system. It is a huge step forward in strengthening cervical cancer screening across India.' 'HPV infection is common. However, persistence of HPV infection could be deadly. Studies show that nearly half of persistent HPV infections do not resolve by 24 months. These silent carriers drive the progression to high-grade pre-cancerous lesions and cancer. That's why extended HPV genotype detection is crucial,' shared Dr Sachdeva. HPV also causes oropharyngeal cancers Oropharyngeal cancers related to HPV vary from 28% to 68% in the richer nations. Indian studies also show alarming numbers though, more research is needed for science-informed responses towards eliminating HPV related cancers in our population, said Dr Ishwar Gilada, President Emeritus of AIDS Society of India (ASI) and Governing Council member of International AIDS Society (IAS). 'While there is increasing evidence of HPV-associated oropharyngeal cancer in both men and women globally, there still remain gaps in gender-neutral HPV vaccination policies globally,' said Dr Sachdeva. Community leaders like Manoj Pardeshi, who is among the co-founders and inspiring lights of NCPI Plus, said that regardless of gender, all those eligible and at risk of HPV related cancers, must be vaccinated against HPV. Programme addressing cervical cancer elimination should expand to eliminate all HPV related cancers in people-centred ways, regardless of gender. HPV is transmitted through: – Sexual contact: Transmission mode is through vaginal, anal, or oral sex with an infected person. – Skin-to-skin contact: Transmitted through non-penetrative sexual activities involving skin-to-skin contact. The WHO Guidelines recommend HPV detection via molecular test after age of 30 (and every 5 years thereafter). Vaccination against HPV is highly recommended for younger people under the age of 15 or before the initiation of sexual activity. Do not leave equity behind 'Truenat HPV-HR Plus test is about equity in detection. By expanding beyond traditional targets, we reach the genotypes that matter more in our populations for cervical cancer elimination. This means earlier intervention, fewer missed cases, and better outcomes,' said Dr Sachdeva. Truenat HPV-HR Plus offers the best of both worlds – critical genotype coverage and real-world deploy-ability. What does it mean to eliminate cervical cancer by 2030? To eliminate cervical cancer, all countries must reach and maintain an incidence rate of below 4 per 100,000 women. Achieving that goal rests on three key pillars and their corresponding targets: vaccination: 90% of all eligible young people must be fully vaccinated with the HPV vaccine by the age of 15. screening: 70% of women should be screened using a high-performance test by the age of 35, and again by the age of 45; treatment: 90% of women with pre-cancer treated and 90% of women with invasive cancer managed. No other cancer but cervical cancer is fully preventable and curable if detected and managed early. Even one death from it is a death too many. Shobha Shukla – CNS (Citizen News Service) (Shobha Shukla is the award-winning founding Managing Editor and Executive Director of CNS (Citizen News Service) and is a feminist, health and development justice advocate. She is a former senior Physics faculty of prestigious Loreto Convent College and current Coordinator of Asia Pacific Regional Media Alliance for Health and Development (APCAT Media) and Chairperson of Global AMR Media Alliance (GAMA received AMR One Health Emerging Leaders and Outstanding Talents Award 2024). She also coordinates SHE & Rights initiative (Sexual health with equity & rights). Follow her on Twitter @shobha1shukla or read her writings here
